A nucleic acid hybridization assay was developed as a sensitive assay for the presence of poliovirus RNA in human tissue. The assay could detect the presence of an average of one poliovirus per 200 cells. A method for determining the extent of degradation of the tissue RNA was developed and used to show that a significant fraction of human central nervous system (CNS) autopsy material contains highly degraded RNA which is unsuitable for hybridization studies. A total of 15 different control and amyotrophic lateral sclerosis tissues were assayed for the presence of poliovirus-like RNA. Virus RNA was detected in one of the control tissues and in none of the ALS tissues.
INTRODUCTION
In the last decade, several central nervous system (CNS) degenerative disease states have been shown to be associated with specific viruses. Work by Padgett et al. (1971) has associated a papovavirus, JC, with progressive multifocal leukoencephalopathy (PML), while Payne et al. (1969) have shown that measles virus is associated with subacute sclerosing panencephalitis (SSPE). These and other findings (Brody & Gibbs, 1974) give plausibility to the concept that viruses may be involved in a wide variety of degenerative CNS diseases. Multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) are other CNS disorders which may have a virus cause. Specifically, measles virus, poliovirus, and influenza virus have been suggested to be associated with MS, ALS and PD respectively.
The possibility of an aetiological role for poliovirus in ALS is recurrent in the neurology literature (Johnson, 1976) . Several studies have suggested that there is a higher incidence of ALS in patients with a past history of paralytic polio than could be explained by chance (Poskanzer et al., 1969) . Anterior horn cells bear the brunt of pathological damage in both poliomyelitis and ALS. In addition, other data are consistent with a poliovirus, or other virus, association with ALS (Kott et al., 1979; Oldstone et al., 1976; Pertschuk et al., 1977) .
Many investigators have failed to isolate an infectious agent from ALS tissue (Cremer et al., 1973) , and it is not yet possible to induce ALS in lower primates by infection with ALS tissue fractions (Zilber et al., 1963; Gibbs & Gajdusek, 1972) . Several investigations have also reported the failure to detect poliovirus nucleic acid in ALS tissue (Viola et al., 1979; Miller et al., 1980; Roos et aI., 1980) . The apparent absence of an infectious agent in ALS tissue may reflect the presence of an easily damaged or mutant virus incapable 0022-1317/81/0000-4483 $02.00 © 1981 SGM of replicating outside the ALS tissue, or inactivation of the virus present by antibodies or virus receptor sites present in the brain.
The failure to detect the presence of poliovirus nucleic acid in ALS autopsy tissue by nucleic acid hybridization was not interpretable in earlier studies due to lack of information concerning the integrity of the ALS tissue nucleic acids used for the assays. Data presented in this paper show that a large fraction of the ALS autopsy tissue contains RNA which is highly degraded and unsuitable for use in a nucleic acid hybridization virus detection test. When it is not known whether a tissue RNA is highly degraded or not, only positive results can be interpreted.
The existing knowledge does not permit a conclusion as to the role of poliovirus, or any other virus, in ALS. The first step in demonstrating a virus role is to establish a correlation between the disease and the presence of the virus. It is not known how many viruses or virus-infected cells are necessary to cause a CNS disease. Particularly in the CNS, relatively few infected cells may have a large and possible lethal effect on the organism. An optimum virus detection test will use the target tissue of the virus and the most sensitive virus detection test possible. Obviously the more sensitive the assay, the more definitive the answer concerning the presence of the virus in the tissue.
The method chosen for virus detection should be specific only for the virus, have the potential for extreme sensitivity of virus detection, and have the ability to detect the virus no matter what form or state of activity the virus is in. The technique of nucleic acid hybridization provides such a method. One portion of the virus, the nucleic acid, must be present if the virus is present at all. Using nucleic acid hybridization, the virus can be detected no matter what the state of activity or form the virus is in. The results reported in a later section show that the poliovirus probe is close to being absolutely specific for the virus and that the sensitivity of virus detection is also extremely high. When used properly, it is more sensitive than the most sensitive virus assays based on antigen-antibody reactions. Given the problems with the virus growth assay, it is likely that nucleic acid hybridization is the most sensitive virus detection method available.
METHODS

Source of virus.
Poliovirus type 1 was a generous gift of Dr John Holland and poliovirus type 2 was obtained from American Type Culture Collection. The viruses were grown in HeLa cells and purified by standard procedures.
Source of tissues. Guamanian tissues were supplied by the National Institute of Neurological and Communicative Disorders and Stroke of the National Institutes of Health. American tissues were obtained by Dr R. A. Smith. Tissues were removed as soon as possible after death and stored at-70 °C.
Nucleic acid isolation. Nucleic acids were purified in two different ways. A standard phenol:chloroform method was used to purify the RNAs reacted with probe I. This standard method was difficult and time consuming when used with spinal cord tissue. A second method was developed to facilitate the isolation of RNA from brain and spinal cord tissue. This method is described below.
Sodium triehloroacetate extraction method. Frozen tissue was added to 5 vol. 2.15 M-sodium trichloroacetic acid (NaTCA) pH 7 to 8 at room temperature, and thoroughly homogenized at room temperature for 2 to 3 min in a Virtis high speed blender at 30000 rev/min. SDS was then added to a final concentration of 0.5 %. Three vol. chloroform and 1 vol. phenol were added to the mixture which was shaken vigorously for 15 min and then centrifuged at 10 °C. The chloroform :phenol extraction was repeated twice more. After the last extraction 2.5 vol. 95% ethanol were added to the aqueous phase. After 2 to 12 h at -20 °C the precipitate was recovered by centrifugation. The pellet consisted of nucleic acid and some protein and was redissolved in a solution of 0.1% SDS, proteinase K (50/~g/ml) and 0.01 M-tris pH 8.1, incubating at 37 °C for 1 h, if necessary, to get the pellet into solution. NaC1 was added to 0.3 M and the mixture extracted with 1 vol. of a 1/1 mix of phenol:chloroform. The aqueous phase was then extracted with 1 vol. chloroform. Ethanol precipitation gave material which was DNase-treated (10 /tg/ml) and then extracted with phenol :chloroform. After ethanol precipitation of the RNA it was redissolved in a small volume of H20 and stored at -70 °C. Poliovirus RNA was purified by the method of Kacian & Myers (1976) .
Iodination of RNA. Standard methodology (Prensky, 1976 ) gave a product with a specific radioactivity of 1 x 106 to 5 x 106 ct/min/ctg. All ~2~I-labelled RNAs were characterized for RNase lability and acid precipitability. The 125I-labelled RNA was typically 98% acidprecipitable, 97 % destroyed by RNase, and hybridized to greater than 95 % with an excess of polio 3H-labelled eDNA.
Production of 3tI labelled eDNA complementary to poliovirus RNA. Two different approaches were used to generate high: specific radioactivity (SRA) 3H-labelled cDNA complementary to the polio virion strand RNA. The method of Kacian & Myers (1976) was used to generate full-sized poliovirus type 1 and 2 3H-labelled cDNA. Undiluted [3H]TTP (50 Ci/mmol) was used yielding 3H-labelled cDNA with a specific radioactivity of about 108 d/min//~g. The high tool. wt. 3H-labelled cDNAs for poliovirus types 1 and 2 were both about 2-4 x 106 daltons in size. These cDNAs were sonicated to a size of about 2 x 10 ~ mol. wt. and characterized for the presence of self complementary 3H-labelled cDNA, 3H-labelled poly(dT), and the non-specific binding of single-strand 3H-labelled eDNA to hydroxyapatite.
An alternative method (D. E. Kohne & S. M. Tracy, unpublished data) was used to produce 3H-labelled cDNA which was greater than 90% representative of the poliovirus RNA. 3H-labelled eDNA was synthesized using the reaction conditions of Kacian & Myers (1976) and oligo calf thymus deoxyribonucleotides as a primer (Taylor et al., 1976) . After removing self-reacting 3H-labelled cDNA and 3H-labelled poly(dT), a sufficient excess of this cDNA was hybridized to radioactive poliovirus RNA in order to completely protect the RNA from RNase. This hybridization mixture was then passed over hydroxyapatite where only the cDNA hybridized to the poliovirus RNA adsorbed. The adsorbed 3H-labelled eDNA was highly representative of poliovirus RNA and was used as probe after eliminating the RNA by alkaline hydrolysis.
Production of human ribosomal RNA 3H-labelled eDNA. High SRA 3H-labeUed eDNA complementary to human 28S ribosomal RNA (rRNA) was prepared by the oligo calf thymus primer method described above.
Hybridization assays. Unless otherwise noted, all nucleic acid hybridization mixes were performed in 0.48 M-phosphate buffer (PB) pH 6.8 at 68 °C. The reaction volumes ranged from 0.015 to 0.05 ml. The standard hydroxyapatite (HA) method was used to assay the reaction mixtures (Kohne & Britten, 1971) . DNA grade HA from BioRad was used. New HA was used for each separate assay and the water-jacketed column was washed thoroughly before each assay.
Since the signal that the 3H-labelled cDNA has hybridized to the tissue RNA is the presence of 3H-Iabelled eDNA in the 0.3 M-PB elution fraction, it is imperative to elute all possible non-hybridized 3H-labelled eDNA from the HA. Care should be exercised to ensure this.
Assay for radioactivity. To assay the hydroxyapatite column effluent for radioactivity, 7.5 ml of column buffer (0.14 M-PB) was mixed with 14 ml Aquasol-2 in a thin-walled plastic scintillation vial. The background for this mixture (no radioactivity added) was 4 or 10 ct/min, depending on the exact window settings used. The 3H counting efficiency was 15 or 25 % depending on the window settings.
Choice of hybridization assay method. The methodology described in this paper allowed the detection of 2 × 10 -13 g of a specific RNA, poliovirus RNA, using a 3H-labelled cDNA with a SRA of 108 d/min//lg. The knowledge gained from this work now makes it possible to increase this sensitivity 10-to 100-fold.
It is often assumed that the use of higher specific activity 32p-labelled cDNA hybridized to RNA immobilized on nitrocellulose paper or diazotized paper and then assayed by autoradiography is the most sensitive hybridization detection method. Thomas (1980) estimated that 10 -11 g of a specific RNA could be detected in a complex population of RNA species using 32p-labelled cDNA of 2 × l0 s to 4 × 108 ct/min//2g SRA. In situ hybridization (Brahic & Hasse, 1978) is an alternate method of virus detection. In theory this method is more sensitive than the one used here. In practice, however, there are serious difficulties in using the in situ method for examining a large tissue mass since a tissue section containing about 105 cells (about 10 -3 g of tissue) is usually assayed. To assay 0.1 g of tissue would require analysis of 100 sections. Assaying even a small part of the human brain would be a large task. The in solution nucleic acid hybridization assay was chosen for this work because of its great sensitivity and the ability to assay large amounts of tissue at one time.
RESULTS
Improved method for nucleic acid extraction
Extraction of spinal cord tissue was very difficult using standard phenol:chloroform procedures. This was greatly simplified when 2.15 M-NaTCA was used in place of the usual solutions. A mixture of spinal cord tissue and a known amount of poliovirus RNA was extracted with NaTCA as described in Methods. The RNA recovered hybridized well with poliovirus all-labelled eDNA and the kinetics of the reaction indicated that more than one-half of the poliovirus RNA was recovered. Three separate mixtures of spinal cord tissue containing either radioactive RNA, DNA or poly(A) were extracted using NaTCA. In all cases, greater than 70% of the radioactivity was recovered along with the tissue RNA. At room temperature, 2.15 M-NaTCA almost completely inhibits the action of ribonucleases A and T 1.
Assay for the integrity of purified CNS tissue RNA : integrity of ribosomal RNA
In most cases, human CNS tissue is not collected and frozen until hours after death. If the tissue is not frozen soon enough after death the nucleic acids will degrade and it will then be useless for assay.
The integrity of the rRNA can be used as a crude marker for the integrity of a tissue RNA since highly degraded rRNA will not react with its complementary all-labelled eDNA and the 3H-labelled cDNA will hybridize to partially degraded rRNA at a slower rate than with intact rRNA. The extent and rate of the hybridization of rRNA 3H-labelled eDNA with the tissue rRNA can then serve as a crude diagnostic test for the integrity of the tissue RNA. A number of CNS tissue nucleic acid preparations were examined (Table 1 ). The 3H-labelled eDNA hardly hybridized at all to RNA from two of the tissues (GP-176, 2-13). Several other CNS tissues yielded RNA which hybridized with the 3H-labelled eDNA at one-half to one-third the control reaction rate. These tissue RNAs were acceptable for virus nucleic acid detection experiments.
The data of Table 1 provide a preliminary view of the integrity of RNAs isolated from human tissue collected at varying times after death and stored for different periods of time. The first 11 tissue samples (GP-168 to 76-356) originated from Guam. Unfortunately, the RNAs from most of these tissues were used before the ribosomal eDNA test was developed. However, four tissues were examined and two (GP-176 and GP-190) were unsuitable for use * Probe I had 1.3% non-specific binding to HA and the values shown have been corrected for this. Probes II and III have the self-reacting, the poly(dT) and the non-specific binding fractions removed. The equivalent of less than one-half copy of cDNA/cell was present in the human RNA and DNA reaction mixtures. t ND, Not done.
with the hybridization assay and one (GP-174) was marginal. The second set of four tissues (2-1 to 2-6) were collected and stored under carefully controlled conditions in the San Diego area by Dr R. A. Smith. All of these tissues, both spinal cord and brain stem, yielded RNA which hybridized well with ribosomal cDNA. Tissues 2-1, 2-4 and 2-6 were obtained from deceased ALS patients while tissue 2-2 originated from a person dying of non-ALS causes.
Characterization of poliovirus 3H-labelled cDNA probes
Three different preparations of poliovirus all-labelled cDNA were used for this work. Each cDNA was checked for the presence of self complementary cDNA and 3H-labelled pdT and for its ability to hybridize to human RNA and DNA and homologous poliovirus RNA. 2 presents these data. Poliovirus 3H-labelled cDNA is highly specific for virus RNA and shows almost no hybridization to human nucleic acids.
The initial experiments with probe I indicated the need to increase the sensitivity of detection as much as possible. One approach to this was to reduce the non-specific binding of the 3H-labelled cDNA to hydroxyapatite. Probes II and III were passed over hydroxyapatite three times to lower the non-specific binding. One to 3 % of the 3H-labelled cDNA was removed by this process and the resulting cDNA gave 0.2% or less non-specific binding.
The stability of probe III 3H-labelled cDNA with time was determined. The 3H-labelled cDNA (0-02/~g/ml) was stored at 4 °C in 10 -3 M-EDTA pH 7.5 and hybridized over 90% with poliovirus RNAs after 243 days of storage.
Nucleotide sequence homologies among different poliovirus RNAs
Data on the nucleotide sequence homology among different types and strains of poliovirus have been reported previously (Young et al., 1968; Young, 1973) . The experiments reported here involve the hybridization of representative poliovirus type 1 3H-labelled cDNA with poliovirus RNAs from different sources. These data (Table 3) corroborate the general nature of the earlier studies. It is clear from these results that, when used in a poliovirus detection test, the 3H-labelled cDNA from one of the poliovirus types will readily detect the presence of the other poliovirus types.
Sensitivity of virus detection tests
The design of a virus detection assay dictates the virus detection sensitivity which can be attained. Most of the virus detection tests done with probe I were designed in such a way that 0.2 copy of poliovirus RNA per cell could easily be detected. These tests are quite similar to that of experiment (c) of Table 4 . In both cases, unstripped [i.e. the poly(A), self reacting and non-specific binding fractions had not been removed] 3H-labelled cDNA was used. This reconstruction virus detection assay demonstrated that such a sensitivity could readily be attained since the fraction of 3H-labelled cDNA adsorbed in (c) (39 %) was almost 39 times higher than the control value of 0.9% (Table 4a ). The presence of one copy of polio RNA/cell gave a very large amount of reaction, 84%. The use of stripped 3H-labelled cDNA for this experiment would have increased the experimental/control ratio to about 350 (84/0.24). Since an experimental/control ratio of 3/1 can be significant, reactions (b) and (c) have an ultimate sensitivity of detection of about one copy of poliovirus RNA per 40 to 80 cells. (d) and (e) are +2 sigma. Polio RNA was reacted with the polio 3H-labelled cDNA in the presence of calf liver RNA. Stripped 3H-labelled cDNA has been processed to remove the poly(rA), self reacting, and non-specific binding fractions. Table 4 present detection tests using the stripped, low background 3H-labelled cDNA, which gave a much lower control adsorption value (about 0-2% of input radioactivity). About 2 % of this 3H-labelled cDNA hybridized with liver RNA containing the equivalent of 1 copy of polio RNA per 100 cells. This is a value about 8 to 10 times higher than the control reaction value of about 0.2 % (Table 4 d, e). Six different HA determinations of the probe II control background value ranged from 0.00 to 0.26 % of the input 3H-labelled cDNA adsorbed to the HA and the average value was 0.19%. Additional checks on this control or background value are provided by the reactions seen when probe II 3H-labelled cDNA was reacted with human CNS RNA from control and diseased tissue (Table 5; GP-168, GP-174, GP-176, GP-190, 2-1, 2-2, 2-4, 2-6). The average of 10 different determinations was 0.33 % binding.
Reactions (d) and (e) of
The design of virus detection tests done with probes II and III was quite similar to that of experiment (e) in Table 4 . The 2% reaction seen for (e) represents about 4.6 ct/min 3H-labelled cDNA. The counting background for this experiment was about 10.5 ct/min. The elution sample immediately preceding the 0.3 M-PB sample contained no detectable radioactivity while the 0.3 M-PB fraction contained 4.6 ct/min above background. Each sample was counted 17 times for 20 min/cycle. This resulted in a count rate of 3570 ct/340 min for the control and the sample just preceding the 0.3 M-PB fraction, and 5134 ct/340 min for the 0.3 M-PB fraction. The 2 sigma standard deviation count rates are 3570 + 119 ct/340 min and 5134 + 143 ct/340 min or 10.5 + 0.35 ct/min and 15.1 + 0.42 ct/min respectively.
Under the counting conditions used, 4.6 ct/min 3H-labelled cDNA was equivalent to about 6 × 104 polioviruses. About one-half this amount of radioactivity can be reliably detected. Thus, the lower limit for significantly detecting radioactivity puts a lower limit on the sensitivity of virus detection. In this case, 30000 virus RNA molecules can be detected. The actual sensitivity of a detection test depends on a variety of factors including the specific 231 radioactivity of the virus probe, the non-specific binding background of the hybridization assay and the hybridization exposure attainable with the nucleic acid mixture used. When these are taken into consideration the sensitivity of the tests using probes II and III is capable of detecting the presence of about 3 x 104 poliovirus particles or about one virus genome per 200 cells.
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Poliovirus detection in CNS tissue
Examination of human CNS tissues for the presence of polio RNA
Fifteen human control and diseased CNS tissue RNAs were assayed for the presence of poliovirus RNA by using poliovirus type 1 3H-labelled cDNA probes I and II, and potiovirus type 2 probe III. These tissues consist of eight Guam ALS cases, three American ALS cases, two Guam Parkinson's disease, one American control and one Guam control case. Poliovirus grows well in the anterior horn cells of the CNS. Since spinal cord is greatly enriched in these cells and is intimately involved in the disease, this tissue type was primarily used for these assays.
No significant extent of hybridization of probe II or probe III 3H-labelled cDNA to tissue RNA was observed (Table 5) . Probe I all-labelled cDNA hybridized to a considerable extent (17.9 %) with spinal cord tissue RNA GP-260, and the test was repeated (Table 5 ) in order to confirm this positive reaction. At a lower hybridization exposure, the repeat experiment showed 9.1% hybridization. In each case, the extent of the reaction increased with time of incubation. The percentage of the probe I 3H-labelled cDNA adsorbed to HA at the highest RNA Cot (i.e. the longest time of incubation) was 17.9% almost 9 times the background control value of 2%. Probe I reacted to a marginal extent with GP-260 cortex (1.5%), GP-348 spinal cord (about 2 %) and GP-349 spinal cord (3.9 %) tissue RNAs.
In interpreting these values, it is important to accurately determine the control or background adsorption of the probe I to HA. Slight changes in the concentration of the column buffer, the presence or absence of RNA, and the amount of HA and 3H-labelled cDNA had little effect on the binding of single-strand probe I all-labelled cDNA to the HA. The average of eight different measurements was 1.8% adsorbed; the range of values was from 1.3 to 2.2% adsorbed.
DISCUSSION
Poliovirus 3H-labelled cDNA is highly specific for poliovirus RNA sequences. No significant hybridization above background could be detected when the all-labelled cDNA was reacted with human RNA from CNS tissue or with human DNA (Tables 2 and 5 ). This demonstrates that poliovirus-specific genetic information does not normally exist in the human genome. In contrast, each poliovirus all-labelled cDNA preparation hybridized to greater than 94 % with its homologous RNA. In addition, the 3H-labelled cDNA prepared for one poliovirus type reacted well with the RNA from another poliovirus type (Table 3) . This means that the probe made from one poliovirus type will also detect the presence of other poliovirus types, if they are present in tissue RNA.
Hybridizable RNA was obtained from diseased as well as normal CNS tissue. However, a significant fraction of the CNS tissues did not yield hybridizable RNA. Negative results are meaningful only if the tissue RNA is capable of hybridizing. If it is not known whether the tissue RNA is capable of hybridizing, a negative result permits no conclusion to be drawn concerning the presence or absence of the virus RNA. To the best of our knowledge, this report is the first to check the tissue RNAs used for virus detection for their ability to hybridize. Many investigators have used nucleic acid hybridization to search for the presence of specific virus RNAs in normal and diseased human tissue and have reported negative results, i.e. the absence of detectable virus RNA in the tissue RNA. Any such result reporting the absence of virus RNA in human CNS tissue RNA must be re-evaluated.
The tissues which did not show the presence of poliovirus RNA cannot be described as having no poliovirus RNA. It can be definitely stated only that less than about 3 x 104 poliovirus RNA molecules are present in the tissue RNA. This is detecting about 10 -19 moles of poliovirus RNA. This level of detection is considerably better than that of the most sensitive radioimmune assays.
Fifteen different human tissue RNAs were examined for the presence of poliovirus-like RNA. Only spinal cord RNA from patient GP-260 showed a clear positive reaction for the presence of poliovirus-like RNA. This test was done twice (Table 5 ) and in both reactions the extent of hybridization increased with time, a feature characteristic of a true hybridization reaction. In addition, the thermal stability profile of the 3H-labelled cDNA adsorbed to the HA from the second reaction showed an elution T m of 75.5 °C and a fairly sharp melting curve. The elution profile of probe I 3H-labelled cDNA: poliovirus type 1 RNA hybrids done under identical conditions shows a sharp elution profile and an elution T m of about 83 °C. The lower T m of the tissue RNA:3H-labelled cDNA hybrids suggests that the virus RNA present in the tissue is not completely homologous to the poliovirus type 1 RNA used to synthesize the probe. Any significant positive reaction will signal the presence of virus RNA in a tissue. However, this by itself does not prove that the virus present is poliovirus. The virus may be polio but may also be an enterovirus related to poliovirus. Coxsackievirus RNA, for example, has 2 to 5 % homology with poliovirus RNA (Young, 1973) . Furthermore, a small nucleotide sequence in all enteroviruses may be highly conserved (Hewlett & Florkiewicz, I980) . The extent of reaction of the poliovirus cDNA with GP-260 RNA was about 19 %. This indicates that the virus RNA in the tissue is not Coxsackie RNA. If the extent of reaction had been 40 to 100%, then the virus RNA present would almost certainly be poliovirus RNA.
At the present stage of knowledge concerning these CNS diseases, the inability to specifically identify a particular virus is not critical. The detection of any virus in normal or diseased tissue will be important. Any new information concerning possible aetiological agents of ALS will be valuable. It is also important to know whether low level persistent virus infections of the CNS are common. Finding such infections in 'normal' humans would have important implications concerning the potential of viruses to cause CNS diseases.
The results presented here are preliminary results and are part of a broader study on the role of viruses in CNS diseases. The initial emphasis has been placed on developing the experimental methodology and rationale for this study. The rationale and technical methodology described here are not limited to the detection of poliovirus and can be applied to the detection of any RNA virus. These studies provide a solid base for an intensive search for the presence of virus RNA in human CNS diseased tissue.
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